Prevention of Yellow Fever in Persons Traveling to the Tropics
Open Access
- 15 May 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 34 (10) , 1369-1378
- https://doi.org/10.1086/340104
Abstract
Yellow fever (YF) is a potentially lethal mosquito-borne viral hemorrhagic fever endemic in Africa and South America. Nine million tourists annuallyKeywords
This publication has 29 references indexed in Scilit:
- Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever VaccinationEmerging Infectious Diseases, 2001
- Hepatitis and death following vaccination with 17D-204 yellow fever vaccineThe Lancet, 2001
- Does Restricted Distribution Limit Access and Coverage of Yellow Fever Vaccine in the United States?Emerging Infectious Diseases, 1998
- In Vivo Synthesis of Tumor Necrosis Factor‐α in Healthy Humans after Live Yellow Fever VaccinationThe Journal of Infectious Diseases, 1998
- Yellow fever vaccination during pregnancy and spontaneous abortion: a case‐control studyTropical Medicine & International Health, 1998
- Yellow fever: a decade of reemergenceJAMA, 1996
- Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adultsVaccine, 1996
- IMPORTED YELLOWFEVER IN VACCINATED TOURISTThe Lancet, 1989
- Simultaneous administration of hepatitis B and yellow fever vaccinesJournal of Medical Virology, 1986
- THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATIONThe Journal of Experimental Medicine, 1937